- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 25th, 2005
Jack Uldrich: Last week, privately-held Dendritic NanoTechnologies Inc. (DNT) announced that it had developed a new family of scalable, precision dendrimer nanostructures. The technology is called Priostar ™ and it could radically change the economics of nanotechnology.
The news is not only important for the emerging nanotech industry, it is especially good news for Dow Chemical (NYSE: DOW) and Starpharma (Nasdaq: SPHRY) -- both of whom own 30% of DNT apiece.
|Related News Press|
Host-guest nanowires for efficient water splitting and solar energy storage February 7th, 2016
Discovery of the specific properties of graphite-based carbon materials February 6th, 2016
PEN Inc. Announces 1-for-180 Reverse Stock Split January 27th, 2016
UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016
Study reveals how herpes virus tricks the immune system February 5th, 2016
Hepatitis virus-like particles as potential cancer treatment February 5th, 2016